(Q42805229)

7 November 2017

title

Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue (English)

1 reference

7 November 2017

0 references

Jaime González-Cuevas

series ordinal

1

1 reference

7 November 2017

Miriam Bueno-Topete

series ordinal

2

1 reference

7 November 2017

Juan Armendariz-Borunda

series ordinal

3

1 reference

7 November 2017

publication date

1 October 2006

1 reference

Journal of Gastroenterology and Hepatology

7 November 2017

published in

1 reference

7 November 2017

volume

21

1 reference

7 November 2017

issue

10

1 reference

7 November 2017

page(s)

1544-1554

1 reference

describes a project that uses

7 November 2017

HSC 180

0 references

cites work

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Plasminogen activator/plasmin system: a major player in wound healing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Improved effects of viral gene delivery of human uPA plus biliodigestive anastomosis induce recovery from experimental biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

uPA and uPAR in fibrinolysis, immunity and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Plasminogen activators direct reorganization of the liver lobule after acute injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Modulation of urokinase-type plasminogen activator by transforming growth factor beta1 in acetaldehyde-activated hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Sensitivity and reproducibility in adenoviral infectious titer determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Comparative electrophoretic analysis of human and porcine plasminogen activators in sds-polyacrylamide gels containing plasminogen and casein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Genomic and functional characterization of stellate cells isolated from human cirrhotic livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Characterization of a TGFbeta-responsive human trophoblast-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04398.X

10.1111/J.1440-1746.2006.04398.X

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference